Citius Oncology, Inc.
NASDAQ:CTOR · NASDAQ Global Market
+$0.03 today
Vol 0.03M · Avg 0.12M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-73.21%
Period High
$5.29
Period Low
$0.49
Latest
$0.67
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Forte Biosciences, Inc.
NASDAQ:FBRX
$248.90M
Fate Therapeutics, Inc.
NASDAQ:FATE
$235.93M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$127.96M
Vor Biopharma Inc.
NASDAQ:VOR
$100.68M
Owlet, Inc.
NYSE:OWLT
$92.46M
LENSAR, Inc.
NASDAQ:LNSR
$69.48M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$63.62M
Scilex Holding Company
NASDAQ:SCLX
$57.49M
Actuate Therapeutics Inc
NASDAQ:ACTU
$50.01M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest CTOR filing?
The latest filing shown is 424B3 dated Jun 1, 2026.
How many recent filings does CTOR have?
Intrinsic Alpha currently shows 20 recent filings for CTOR.
Explore More
Continue the stock analysis
Jump to another research area for this company.